Archive · 19 Sep 2025
Aspirin Found to Reduce Colon Cancer Recurrence Risk
Imagine your body has a problem called colon cancer, and you had surgery to fix it.
A study found that taking a common pain reliever, like aspirin, can help prevent the cancer from coming back.
This study looked at many people who had surgery for colon cancer.
Those whose cancer had a specific tiny change, called a mutation, seemed to benefit the most.
They took a low dose of aspirin every day for three years.
The results showed a big drop in the chance of the cancer returning.
This helps doctors find new ways to protect people and make them live longer.
Study reveals aspirin may reduce the risk of colon cancer recurrence after surgery.
The study analyzed the effects of aspirin on colorectal cancer patients.
Patients with specific mutations in the PI3K signaling pathway saw better outcomes.
Participants took 160 mg of aspirin daily for three years after surgery.
Aspirin reduced recurrence risk by approximately 55% in those with the specific mutation.
- Who
- Researchers and patients with colon cancer
- What
- A study showing aspirin can reduce colon cancer recurrence.
- When
- After surgery
- Where
- Sweden, Norway, Denmark, and Finland
- Why
- To investigate aspirin's impact on colon cancer relapse
- Study Focus
- Aspirin's effect on colon cancer recurrence
- Dosage
- 160mg aspirin daily
- Duration
- 3 years after surgery
- Study Name
- ALASCCA
- Participants
- 3,508 patients
- Reduction in Recurrence
- 55% for specific mutation group